Chicago Capital’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-22,593
| Closed | -$191K | – | 364 |
|
|
2025
Q3 | $191K | Sell |
22,593
-17,646
| -44% | -$171K | ﹤0.01% | 355 |
|
|
2025
Q2 | $453K | Sell |
40,239
-913
| -2% | -$8.38K | 0.01% | 263 |
|
|
2025
Q1 | $390K | Buy |
41,152
+10,018
| +32% | +$101K | 0.01% | 264 |
|
|
2024
Q4 | $350K | Buy |
31,134
+21,061
| +209% | +$370K | 0.01% | 253 |
|
|
2024
Q3 | $285K | Hold |
10,073
| – | – | 0.01% | 271 |
|
|
2024
Q2 | $193K | Hold |
10,073
| – | – | 0.01% | 301 |
|
|
2024
Q1 | $330K | Hold |
10,073
| – | – | 0.01% | 243 |
|
|
2023
Q4 | $333K | Hold |
10,073
| – | – | 0.01% | 229 |
|
|
2023
Q3 | $274K | Hold |
10,073
| – | – | 0.01% | 193 |
|
|
2023
Q2 | $305K | Hold |
10,073
| – | – | 0.01% | 190 |
|
|
2023
Q1 | $327K | Hold |
10,073
| – | – | 0.02% | 183 |
|
|
2022
Q4 | $283K | Hold |
10,073
| – | – | 0.02% | 192 |
|
|
2022
Q3 | $362K | Hold |
10,073
| – | – | 0.02% | 182 |
|
|
2022
Q2 | $309K | Hold |
10,073
| – | – | 0.02% | 198 |
|
|
2022
Q1 | $325K | Hold |
10,073
| – | – | 0.01% | 209 |
|
|
2021
Q4 | $279K | Hold |
10,073
| – | – | 0.01% | 219 |
|
|
2021
Q3 | $312K | Hold |
10,073
| – | – | 0.01% | 209 |
|
|
2021
Q2 | $213K | Hold |
10,073
| – | – | 0.01% | 232 |
|
|
2021
Q1 | $203K | Hold |
10,073
| – | – | 0.01% | 236 |
|
|
2020
Q4 | $161K | Hold |
10,073
| – | – | 0.01% | 227 |
|
|
2020
Q3 | $125K | Hold |
10,073
| – | – | 0.01% | 224 |
|
|
2020
Q2 | $72K | Hold |
10,073
| – | – | ﹤0.01% | 226 |
|
|
2020
Q1 | $55K | Hold |
10,073
| – | – | ﹤0.01% | 193 |
|
|
2019
Q4 | $91K | Hold |
10,073
| – | – | 0.01% | 218 |
|
|
2019
Q3 | $72K | Sell |
10,073
-1,352
| -12% | -$9.7K | ﹤0.01% | 215 |
|
|
2019
Q2 | $91K | Buy |
11,425
+904
| +9% | +$10.7K | 0.01% | 223 |
|
|
2019
Q1 | $132K | Sell |
10,521
-1,510,735
| -99% | -$23.9M | 0.01% | 208 |
|
|
2018
Q4 | $30.3M | Buy |
1,521,256
+113,799
| +8% | +$2.63M | 2.47% | 7 |
|
|
2018
Q3 | $40M | Buy |
1,407,457
+120,462
| +9% | +$2.87M | 2.77% | 4 |
|
|
2018
Q2 | $27.1M | Buy |
1,286,995
+427,081
| +50% | +$8.08M | 2.18% | 10 |
|
|
2018
Q1 | $12.3M | Buy |
+859,914
| New | +$12.3M | 1.64% | 28 |
|
Other funds holding EVH
CCM
RF
EC
Chicago Capital's EVH Position: Q4 2025 in Review
Chicago Capital sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 22,593 shares — an estimated $191K sold.
Chicago Capital first reported a position in EVH in Q1 2018 and held it in 31 quarters. The position peaked at $40M in Q3 2018. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.
- Chicago Capital reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
- Chicago Capital sold 22,593 Evolent Health shares in Q4 2025, an estimated $191K.
- Chicago Capital first reported a position in Evolent Health in Q1 2018 and held it in 31 quarters.
- Chicago Capital's Evolent Health position peaked at $40M in Q3 2018.
- 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.
Based on Chicago Capital's 13F filing for Q4 2025, filed 26 Jan 2026.